These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 11465081)
1. The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates. Järvinen E; Deng F; Kiander W; Sinokki A; Kidron H; Sjöstedt N Front Pharmacol; 2021; 12():802539. PubMed ID: 35095509 [TBL] [Abstract][Full Text] [Related]
2. Transacylation and hydrolysis of the acyl glucuronides of ibuprofen and its α-methyl-substituted analogues investigated by Richards SE; Bradshaw PR; Johnson CH; Stachulski AV; Athersuch TJ; Nicholson JK; Lindon JC; Wilson ID J Pharm Biomed Anal; 2024 Aug; 246():116238. PubMed ID: 38805849 [TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients. Hammond TG; Meng X; Jenkins RE; Maggs JL; Castelazo AS; Regan SL; Bennett SN; Earnshaw CJ; Aithal GP; Pande I; Kenna JG; Stachulski AV; Park BK; Williams DP J Pharmacol Exp Ther; 2014 Aug; 350(2):387-402. PubMed ID: 24902585 [TBL] [Abstract][Full Text] [Related]
4. Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice. Fendt R; Ghallab A; Myllys M; Hofmann U; Hassan R; Hobloss Z; González D; Brackhagen L; Marchan R; Edlund K; Seddek AL; Abdelmageed N; Blank LM; Schlender JF; Holland CH; Hengstler JG; Kuepfer L Front Pharmacol; 2023; 14():1279357. PubMed ID: 38053838 [No Abstract] [Full Text] [Related]
5. Thalidomide metabolism and hydrolysis: mechanisms and implications. Lepper ER; Smith NF; Cox MC; Scripture CD; Figg WD Curr Drug Metab; 2006 Aug; 7(6):677-85. PubMed ID: 16918319 [TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of major phase I and II metabolites of ibuprofen. Kepp DR; Sidelmann UG; Hansen SH Pharm Res; 1997 May; 14(5):676-80. PubMed ID: 9165543 [No Abstract] [Full Text] [Related]
8. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma. Fields GB Cells; 2019 Aug; 8(9):. PubMed ID: 31461880 [TBL] [Abstract][Full Text] [Related]
9. Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship study. Fuerst R; Yong Choi J; Knapinska AM; Smith L; Cameron MD; Ruiz C; Fields GB; Roush WR Bioorg Med Chem; 2018 Oct; 26(18):4984-4995. PubMed ID: 30249495 [TBL] [Abstract][Full Text] [Related]
10. New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation. Gunduz M; Argikar UA; Cirello AL; Dumouchel JL Drug Metab Lett; 2018; 12(2):84-92. PubMed ID: 29886840 [TBL] [Abstract][Full Text] [Related]
11. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS. Fallon JK; Smith PC; Xia CQ; Kim MS Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525 [TBL] [Abstract][Full Text] [Related]
12. Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac. Scialis RJ; Csanaky IL; Goedken MJ; Manautou JE Drug Metab Dispos; 2015 Jul; 43(7):944-50. PubMed ID: 25897176 [TBL] [Abstract][Full Text] [Related]